Trinity Biotech Plc (TRIB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TRIB Annual Balance Sheets →
Examining balance sheet movements between Trinity Biotech Plc and Dec 31 2024 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents5.14
Current Tax Assets Current0.46
Cash & Short-term Investments5.00
Accounts receivable0.00
Inventories18.83
Other Current Assets11.48
Total Current Assets35.90
Equipment/Property/Plant Net5.30
Deferred Tax Assets3.92
Intangible AssetsAnd Goodwill56.99
Total Assets105.17
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.00
Longterm Borrowings0.00
Other Liabilities, Current140.86
Current Provisions0.35
Total Current Liabilities141.21
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI4.67
Noncurrent Provisions31.27
Total Liabilities177.15
Stockholders' Equity
Other Equity-71.98
Common Stockholder's Equity-71.98
Total Stockholder's Equity-71.98
Liabilities & Stockholder's Equity105.17
4 historic quarters locked

Sign in to unlock the full Trinity Biotech Plc balance sheet history.

About Trinity Biotech Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001554855-26-000848

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.